Search

everythinglearnresearchcommunity

for

Search:↓

FGF21 can help reduce skin inflammation caused by C. acnes.

TGFβ signaling prevents sebaceous gland cells from producing fats.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Stem cells have great potential for improving wound healing, but more research is needed to find the best types and ways to use them.

Thymosin β4 helps improve skin healing and reduce scarring.

Cultured dermal papilla cells can regenerate hair follicles and sustain hair growth.

The study suggests that people with rosacea are more likely to have chronic rhinosinusitis.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Human alpha defensin 5 helps heal wounds, reduce bacteria, and grow hair on burned skin.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

UV-B light increases inflammation-related substances in acne-related skin cells.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.